Here’s a roundup of this week’s coronavirus-related news.
According to the COVID Tracking Project, the latest totals for coronavirus disease 2019 (COVID-19) in the US have surpassed 12 million cases, with approximately 250,925 deaths, as of November 24. Additionally, approximately 88,000 individuals are currently hospitalized with COVID-19 in the US, reaching a new all-time high for the 15th consecutive day.1
This week, AstraZeneca reported interim data on efficacy for its COVID-19 vaccine candidate, AZD1222, and the Infectious Disease Society of America led a webcast on currently available treatment options.
Here’s a roundup of the latest coronavirus-related news:
AstraZeneca Reports COVID-19 Vaccine Met Primary Efficacy End Point
One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.
Infectious Disease Society of America Webcast Discusses Available COVID-19 Treatments
Infectious Disease Society of America offered a look at the current treatment options for COVID-19 and stressed the need to maintain precautions to keep people safe.
MJH COVID-19 Coalition Surveyed on Mask Mandates, Vaccines, and More
As COVID-19 cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.
Looking at the Epidemiology of COVID-19 in Pediatrics
A new study examines the epidemiology of pediatric COVID-19 cases in a large cohort, Contemporary Pediatrics reported.
Reference
1. The COVID Tracking Project. Data. November 24, 2020. Accessed November 25, 2020. https://covidtracking.com/data
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
2 Commerce Drive
Cranbury, NJ 08512